News
-
Eccentric exercise
Friday | Apr 7 2017CONTRARY to intuitive understandings, walking downstairs appears to have more beneficial effects on the health of obese people than walking upstairs, according to researchers from Edith Cowan University's School of Medical and Health Sciences.
-
Dengue vax trial
Friday | Apr 7 2017JAPANESE pharmaceutical giant Takeda has announced the enrolment of over 20,000 children and adolescents in a global Phase 3 trial of the company's new vaccine candidate for dengue fever.
-
iNova bids below expectations
Friday | Apr 7 2017VALEANT Pharmaceuticals is reportedly "weighing its options" for iNova, its Australian subsidiary, after final bids in a sale process for the business (PD 23 Sep 2016) have come in much lower than the $1 billion expected.
-
FDA biosimilar guidance
Friday | Apr 7 2017WHILE Australia has taken on the relatively simplistic a-flagging policy for biosimilars using the in-situ pharmacy substitution approach used for small molecule generics (PD 04 Apr), the US Food and Drug Administration (FDA) is adopting a more complex approach, releasing its draft guidance on biosimilar interchageability for consultation, noting that there is "no single data package that will work for all proposed interchangeable products.
-
NZ reconsiders codeine
Friday | Apr 7 2017AUTHORITIES in New Zealand have confirmed that the country's Medicines Classification Committee will consider whether codeine based medicines should become prescription only.
-
Travel Specials 06 Apr 17
Thursday | Apr 6 2017REGENT SEVEN SEAS CRUISES 2018-19: Regent Seven Seas Cruises has announced its 2018-2019 Voyage Collection as a celebration of travel, featuring fascinating, often remote, ports of call across more than 100 itineraries.
-
Charges exemption
Thursday | Apr 6 2017THE Therapeutic Goods Administration has summarised its Annual charge exemption (ACE) highlighting that all new entries on the ARTG automatically qualify so that sponsors will not be invoiced for an annual charge until their product generates turnover.
-
Uniden monitors
Thursday | Apr 6 2017TECHNOLOGY brand Uniden has launched its range of baby monitors into Australian pharmacies, identifying the sector as a "natural fit" for the company.
-
RB class action stands
Thursday | Apr 6 2017DESPITE Reckitt Benkiser's attempted interlocutory application filed in the Federal Court on 10 Mar for a 'class closure' in the class action against it around the Nurofen Specific Pain Range products, the court has ruled that it is not in the interests of justice to make any form of order limiting the number of participants in the case.